Bruner, Michael J. Ph.D.

Current Employment Position(s)

Associate

Lawyer Overview

Michael focuses his intellectual property practice on chemical, pharmaceutical, and biotechnology innovations. In particular, he has experience with patent issues relating to small molecule pharmaceuticals, formulations, antibodies, medical devices, and paper technology. Michael has worked with multinational companies, start-ups, and universities.

Michael worked as a law clerk at Pennie & Edmonds from 2001 through 2003 while attending law school in the evening. He has conducted research in the areas of enzymology and vaccine development and has published several articles on transition-state analysis of enzyme catalyzed reactions.

Areas of Practice

• Intellectual Property
• Patent Prosecution
• Licensing & Technology Transactions
• Life Sciences
• Pharmaceuticals

Representative Cases

• Bioenvision develops patent portfolios for Clolar® and Modrenal®
• Celgene establishes global patent portfolio for small molecule pharmaceuticals , (2009)
• Esperion establishes patent portfolios for small molecule cholesterol-lowering drugs
• Georgia-Pacific faces Nat'l Gypsum parent in DJ action over wallboards
• Signal Pharmaceuticals maintains patent portfolio for small molecule kinase inhibitors , (2009)
• Symphony Capital forms joint venture with Lexicon Pharmaceuticals

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Bar Admissions

• Georgia
• New York

Education

• Fordham University
• U of Florida
• U of West Florida

Published Works

• Evaluation of Synthetic, M type-specific Peptides as Antigens in a Multivalent Group A Streptococcal Vaccine, coauthor, Vaccine 21:2698, 2003
• Multivalent Peptide Vaccine Against Group A Strep M Proteins Looks Promising, coauthor, Reuters Medical News, 2001
• Use of an Altered Nucleotide Substrate to Unmask the Transition-State for Rat Liver a(2-6) Sialyltransferase, coauthor, Biochemistry 39:2261, 2000
• The N-Acetyl Neuraminyl Oxocarbenium Ion is an Intermediate in the Presence of Anionic Nucleophiles, coauthor, J. Am. Chem. Soc. 120:1357, 1998
• Isotope Trapping and Kinetic Isotoope Effect Studies of Rat Liver a(2-6) Sialyltransferase, coauthor, Biochemistry 37:289, 1998
• Acid-Catalyzed Solvolysis of CMP-NeuAc: Evidence for a Sialyl Cation with a Finite Lifetime, coauthor, J. Am. Chem. Soc. 118:10371, 1996

Address

1420 Peachtree Street, N.E.,
Suite 800
Atlanta, GA 30309-3053

Phones

1.404.581.8614 (Business Phone)

Faxes

1.404.581.8330 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com